Clinical Trials Logo

Clinical Trial Summary

Colorectal cancer is the second leading cause of death in the West, and rectal cancer accounts for about 25% of colon cancers Low anterior resection has been the mainstay of rectal cancer surgery in low rectal cancer since the 1970s. Although the best efforts of experienced surgeons, The local recurrence rate is 3 to 33% in conventional surgery, while total mesorectal excision (TME) results indicate a recurrence rate of less than 10% The evolution of the concept of TME which was first revealed by Heald.in 1982 made a major shift in the treatment strategies (Rodriguez-Luna et al,2015). The concept of TME was the most important event in surgery for rectal cancer in the last two decades, because even without a curative approach, the local recurrence decreased to 6 to 12%, and 5-year survival improved by 53-87% TME described clear definitions of distal resection margin (DRM), circumferential resection margin (CRM), and least number of harvested lymph nodes, so oncological outcomes improved, locoregional recurrence and survival rates also influenced . Laparoscopic total mesorectal excision (LTME) may be associated with less blood loss, earlier recovery, and lower morbidity. Identification of the small nerves and vessels became easiear because of laparoscopic magnified view of pelvis and thus prevents these injuries (Sajid et al, 2019). Also, minimal surgical trauma will reduce the immunologic response and preserves postoperative immunologic defenses. This may lead to low rate of infections as well as low local recurrences and distant metastases in addition to, tissue handling with less manipulation, 'may reduces the spread of cancer cells TME in obese males with low and anterior rectal tumors is technically challenging especially post neoadjuvant chemoradiotherapy due to distortion of the anatomical planes (Ng et al, 2014). In these patients, it is difficult to obtain a proper view of the dissection plane, in open technique which threatens the integrity of TME and carries the risk of positive margins, which is related to higher rates of local recurrence LTME is a widely used approach for rectal cancers; although conversion rate varies from 1.2 to 17%, and it is higher if BMI is equal to or more than 30


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05685680
Study type Interventional
Source Sohag University
Contact osama s saleh, assistant lecture
Phone 01119966457
Email usama.mohamed@med.sohag.edu.eg
Status Recruiting
Phase N/A
Start date December 20, 2022
Completion date December 20, 2023

See also
  Status Clinical Trial Phase
Active, not recruiting NCT01227239 - Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting Phase 1/Phase 2
Recruiting NCT01459328 - Resource-Sparing Curative Treatment for Rectal Cancer Phase 3
Recruiting NCT04078828 - PR in Endoscopic LAR for Rectal Cancer N/A
Not yet recruiting NCT06424522 - A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients Early Phase 1
Terminated NCT02797405 - Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay N/A
Completed NCT01751516 - PET/MRI as a Predictor of Response to Pre-op Chemoradiation in Resectable Rectal Cancer: a Pilot Study
Terminated NCT01111292 - Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia Phase 1/Phase 2
Completed NCT00682786 - Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma Phase 2
Completed NCT02000050 - Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE) Phase 2
Recruiting NCT04749108 - Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma Phase 2/Phase 3
Active, not recruiting NCT01696981 - Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial) N/A
Active, not recruiting NCT01899547 - Laparoscopy-Assisted Surgery for Carcinoma of the Low Rectum N/A
Completed NCT01333709 - Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma Phase 2
Recruiting NCT04848311 - Indocanine Green as Tracer for Lymph Nodes Dissection in Station 253 N/A
Not yet recruiting NCT02770911 - Laparoscopic Anterior Resection With or Without "Dog Ear" Double-stapled Anastomosis for Rectal Cancer Phase 3
Active, not recruiting NCT02432963 - Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy Phase 1
Active, not recruiting NCT04505553 - Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer Phase 2
Completed NCT01372007 - Influence of Somatuline Autogel 120mg on Post-operative Drainage After Total Mesorectum Excision for Rectumcarcinoma Phase 3
Active, not recruiting NCT02817126 - Robot-assisted Versus Laparoscopic Surgery for Mid/Low Rectal Cancer N/A
Completed NCT02551237 - Neoadjuvant Treatment for Advanced Rectal Carcinoma Phase 3